Who makes BAY987516, X72-151?

BAY987516, X72-151 is developed by Bayer.

What development phase is BAY987516, X72-151 in?

BAY987516, X72-151 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

BAY987516, X72-151

Bayer · Phase 1 active Small molecule

At a glance

Generic name	BAY987516, X72-151
Sponsor	Bayer
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BAY987516, X72-151 CI brief — competitive landscape report
BAY987516, X72-151 updates RSS · CI watch RSS
Bayer portfolio CI